Kyorin Pharmaceutical obtains approval for additional indication for pediatric use of Flutiform® 50 Aerosol, a combination drug for asthma treatment
June 29, 2020
Adobe Reader software is required to view and print PDF files. The latest version of Adobe Reader can be downloaded by accessing the Adobe Systems Incorporated website.